Founders Capital Management (Texas)’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.1K Hold
2,000
0.01% 226
2026
Q1
$12K Hold
2,000
0.01% 303
2025
Q4
$14.3K Buy
+2,000
New +$15.8K 0.01% 278
2023
Q2
Sell
-125
Closed -$3K 402
2023
Q1
$3K Hold
125
﹤0.01% 358
2022
Q4
$3K Hold
125
﹤0.01% 352
2022
Q3
$3K Sell
125
-50
-29% -$1.51K ﹤0.01% 360
2022
Q2
$6K Buy
+175
New +$6.13K ﹤0.01% 356
2021
Q3
Sell
-2,722
Closed -$82K 325
2021
Q2
$82K Buy
+2,722
New +$89.6K 0.05% 91

Other funds holding OGN

Founders Capital Management (Texas)'s OGN Position: Q2 2026 in Review

Founders Capital Management (Texas) held its Organon & Co (OGN) position steady in Q2 2026 at 2,000 shares worth $27.1K. The position accounts for 0.01% of the portfolio, ranked #226.

Founders Capital Management (Texas) first reported a position in OGN in Q2 2021 and has held it in 8 quarters since. The position peaked at $82K in Q2 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Founders Capital Management (Texas) held 2,000 shares of Organon & Co worth $27.1K as of Q2 2026.
  • Founders Capital Management (Texas) left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up 0.01% of Founders Capital Management (Texas)'s portfolio in Q2 2026, its #226 holding.
  • Founders Capital Management (Texas) first reported a position in Organon & Co in Q2 2021 and has held it in 8 quarters since.
  • Founders Capital Management (Texas)'s Organon & Co position peaked at $82K in Q2 2021.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q2 2026, filed 21 Jul 2026.